MedTrace Logo

Evaluation of a Family-centered Program for Problematic Gaming/Excessive Screen Use

NCT07245862 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 170

Last updated 2026-04-30

No results posted yet for this study

Summary

The Family-Centered Program for Problematic Gaming and Excessive Screen Use (FAME) is a pioneering initiative designed to address the growing challenges of excessive screen use and gaming among children and adolescents, particularly within family dynamics.

Conditions

  • Adolescent Behavior
  • Social Media Addiction
  • Gaming Disorder
  • Family Relations

Interventions

BEHAVIORAL

Family-centered Program for Problematic Gaming/Excessive Screen Use in a child and adolescent population within Social Services

The critical components include psychoeducation, cognitive restructuring, and social and emotional learning.his would be the first intervention offering help for both children and their parents. Such an intervention could be beneficial not only to individual families, but also to society at large by reducing societal costs, enhancing family well-being, and addressing health inequalities . the intervention is agroup intervention in 4 sessions with parents in one group and children in one group. The goals are to help children and parents understand the positive and negative aspects of screen use and to prevent related problems and family conflicts. T

BEHAVIORAL

Control

This group will recieve TAU == treat ment as usual depending on the practice at the Social service they belong to

Sponsors & Collaborators

  • Lund University

    collaborator OTHER

  • Region Skane

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
11 Years
Max Age
14 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-01-01
Primary Completion
2027-01-01
Completion
2028-01-01

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07245862 on ClinicalTrials.gov